SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Pfenex Inc. – ‘S-1MEF’ on 4/24/15

On:  Friday, 4/24/15, at 6:12am ET   ·   Effective:  4/24/15   ·   Accession #:  1193125-15-145112   ·   File #s:  333-203418, 333-203600

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 4/24/15  Pfenex Inc.                       S-1MEF      4/24/15    3:95K                                    RR Donnelley/FA

Registration of Additional Securities   —   Form S-1
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-1MEF      Registration of Additional Securities               HTML     26K 
 2: EX-5.1      Opinion re: Legality                                HTML     10K 
 3: EX-23.1     Consent of Experts or Counsel                       HTML      5K 


S-1MEF   —   Registration of Additional Securities


This is an HTML Document rendered as filed.  [ Alternative Formats ]



  S-1MEF  

As filed with the Securities and Exchange Commission on April 24, 2015

Registration No. 333-            

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

FORM S-1

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933

 

 

PFENEX INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware 2834 26-1356759

(State or other jurisdiction of

incorporation or organization)

 

(Primary Standard Industrial

Classification Code Number)

 

(I.R.S. Employer

Identification Number)

 

 

10790 Roselle Street

San Diego, CA 92121

(858) 352-4400

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

 

Bertrand C. Liang M.D., Ph.D.

Chief Executive Officer

Pfenex Inc.

10790 Roselle Street

San Diego, CA 92121

(858) 352-4400

(Name, address, including zip code, and telephone number, including area code, of agent for service)

 

 

Copies to:

Jeffrey D. Saper

Daniel R. Koeppen

Wilson Sonsini Goodrich & Rosati

Professional Corporation

12235 El Camino Real, Suite 200

San Diego, CA 92130

(858) 350-2300

 

Paul A. Wagner

Chief Financial Officer

Pfenex Inc.

10790 Roselle Street

San DiegoCA 92121

(858) 352-4400

 

Christopher Lueking

Latham & Watkins LLP

330 North Wabash Avenue, Suite 2800

Chicago, IL 60611

(312) 876-7700

 

 

Approximate date of commencement of proposed sale to the public: As soon as practicable after this registration statement becomes effective.

If any of the securities being registered on this form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, as amended, check the following box.  ¨

If this form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.  x    333-203418

If this form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.  ¨

If this form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer   ¨    Accelerated filer   ¨
Non-accelerated filer   x (do not check if a smaller reporting company)    Smaller reporting company   ¨

 

 

CALCULATION OF REGISTRATION FEE

 

 

Title of Each Class of

Securities to be Registered

 

Amount

to be
Registered(1)

  Proposed
Maximum
Offering Price
Per Share
 

Proposed
Maximum
Aggregate

Offering Price(2)

 

Amount of

Registration Fee(3)

Common Stock, par value $0.001 per share

  1,000,000   $15.50   $15,500,000   $1,801.10

 

 

(1) Represents only the additional number of shares being registered. Does not include the securities that registrant previously registered on Registration Statement on Form S-1 (File No. 333-203418), as amended (the “Registration Statement”).
(2) The registrant previously registered securities with an aggregate offering price not to exceed $95,737,500 on the Registration Statement, which was declared effective by the Securities and Exchange Commission on April 23, 2015. In accordance with Rule 462(b) under the Securities Act of 1933, as amended (the “Securities Act”), an additional amount of securities having a proposed maximum aggregate offering price of no more than 20% of the maximum aggregate offering price of the securities eligible to be sold under the Registration Statement, or $15,500,000, is hereby registered.
(3) Calculated pursuant to Rule 457(a) under the Securities Act.

 

 

This Registration Statement shall become effective upon filing with the Securities and Exchange Commission in accordance with Rule 462(b) under the Securities Act of 1933, as amended.

 

 

 


EXPLANATORY NOTE AND INCORPORATION BY REFERENCE

Pursuant to Rule 462(b) under the Securities Act of 1933, as amended, Pfenex Inc., a Delaware corporation, is filing this registration statement with the Securities and Exchange Commission, or SEC. This registration statement relates to the public offering of securities contemplated by the Registration Statement on Form S-1, as amended (File No. 333-203418), which we originally filed on April 15, 2015, or the Registration Statement, and which the SEC declared effective on April 23, 2015.

We are filing this registration statement for the sole purpose of increasing the aggregate number of shares of common stock, par value $0.001 per share, offered by us by 310,000 shares and the number of shares offered by certain of our selling stockholders by 690,000 shares. The additional shares of common stock that are being registered for issuance and sale are in an amount and at a price that together represent no more than 20% of the maximum aggregate offering price set forth in the Calculation of Registration Fee table contained in the Registration Statement. The information set forth in the Registration Statement is incorporated by reference in this filing.

The required opinions and consents are listed on the Exhibit Index attached hereto and filed herewith.


SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of San Diego, State of California, on April 24, 2015.

 

PFENEX INC.
By:  

/s/ Bertrand C. Liang

  Bertrand C. Liang, M.D., Ph.D.
  President, Chief Executive Officer, Secretary, and Director

Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed below by the following persons in the capacities and on the dates indicated.

 

Signature

  

Title

 

Date

/s/ Bertrand C. Liang

  

President, Chief Executive Officer and

Director (Principal Executive Officer)

  April 24, 2015
Bertrand C. Liang, M.D., Ph.D.     

/s/ Paul A. Wagner

  

Chief Financial Officer (Principal Financial

Officer)

  April 24, 2015
Paul A. Wagner, Ph.D.     

/s/ Patricia Lady

  

Chief Accounting Officer (Principal

Accounting Officer)

  April 24, 2015
Patricia Lady     

*

   Director   April 24, 2015
William R. Rohn     

*

   Director   April 24, 2015
Robin D. Campbell     

*

   Director   April 24, 2015
Phillip M. Schneider     

 

   Director   April 24, 2015
John M. Taylor     

 

*By:  

/s/ Bertrand C. Liang

 

Bertrand C. Liang, M.D., Ph.D.

Attorney-in-fact


EXHIBIT INDEX

 

Exhibit
Number

   Description of Exhibit
  5.1    Opinion of Wilson Sonsini Goodrich & Rosati, Professional Corporation.
23.1    Consent of Haskell & White, LLP, Independent Registered Public Accounting Firm.
23.2    Consent of Wilson Sonsini Goodrich & Rosati, Professional Corporation (included in exhibit 5.1).
24.1    Powers of Attorney (incorporated by reference to Exhibit 24.1 of the Form S-1 Registration Statement (Registration No. 333-203418)).

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘S-1MEF’ Filing    Date    Other Filings
Filed on / Effective on:4/24/15
4/23/154,  S-1/A
4/15/15S-1
 List all Filings 
Top
Filing Submission 0001193125-15-145112   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., Apr. 18, 5:37:32.1pm ET